In the present study, the SET8 inhibitor UNC0379 was identified as a potent anti-fibrotic agent using an assay system utilizing myofibroblasts from IPF-affected lung tissue. This evidence concerns the gene KMT5A and idiopathic pulmonary fibrosis.